Cara Therapeutics (STU:69C) Days Payable : 0.00 (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Cara Therapeutics Days Payable?

Cara Therapeutics's average Accounts Payable for the three months ended in Sep. 2024 was €4.28 Mil. Cara Therapeutics's Cost of Goods Sold for the three months ended in Sep. 2024 was €0.00 Mil.

The historical rank and industry rank for Cara Therapeutics's Days Payable or its related term are showing as below:

STU:69C' s Days Payable Range Over the Past 10 Years
Min: 382.51 Med: 504.4 Max: 2011.36
Current: 2011.36

During the past 13 years, Cara Therapeutics's highest Days Payable was 2011.36. The lowest was 382.51. And the median was 504.40.

STU:69C's Days Payable is ranked better than
88.94% of 714 companies
in the Biotechnology industry
Industry Median: 127.14 vs STU:69C: 2011.36

Cara Therapeutics's Days Payable declined from Sep. 2023 (583.65) to Sep. 2024 (0.00). It may suggest that Cara Therapeutics accelerated paying its suppliers.

Cara Therapeutics Days Payable Historical Data

The historical data trend for Cara Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cara Therapeutics Days Payable Chart

Cara Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

373.67

634.59

Cara Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															583.65	1,479.71	1,216.83	-	-

Competitive Comparison of Cara Therapeutics's Days Payable

For the Biotechnology subindustry, Cara Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cara Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cara Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Cara Therapeutics's Days Payable falls into.

Cara Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Cara Therapeutics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (9.066	+	10.622)	/	2 )	/	5.662	*	365
=	9.844					/	5.662	*	365
=	634.59

Cara Therapeutics's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (6.275	+	2.289)	/	2 )	/	0	*	365 / 4
=	4.282					/	0	*	365 / 4
=	N/A

Cara Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Cara Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cara Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cara Therapeutics Inc (STU:69C) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

CARA:USA 0HTC:UK 69C:Germany

Address

400 Atlantic Street, Suite 500, Stamford, CT, USA, 06901

Website

https://www.caratherapeutics.com

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Cara Therapeutics Headlines

No Headlines